These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7862854)

  • 1. Aversive properties of the kappa opioid agonist U50,488 in the week-old rat pup.
    Barr GA; Wang S; Carden S
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):422-8. PubMed ID: 7862854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U50,488 increases ultrasonic vocalizations in 3-, 10-, and 18-day-old rat pups in isolation and the home cage.
    Carden SE; Davachi L; Hofer MA
    Dev Psychobiol; 1994 Jan; 27(1):65-83. PubMed ID: 8112489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonic vocalizations are elicited from rat pups in the home cage by pentylenetetrazol and U50,488, but not naltrexone.
    Carden SE; Bortot AT; Hofer MA
    Behav Neurosci; 1993 Oct; 107(5):851-9. PubMed ID: 8280394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of kappa-opioid-receptor stimulation on neonatal rats.
    Kehoe P; Boylan CB
    Behav Neurosci; 1994 Apr; 108(2):418-23. PubMed ID: 8037885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa receptors mediate the peripheral aversive effects of opiates.
    Bechara A; van der Kooy D
    Pharmacol Biochem Behav; 1987 Oct; 28(2):227-33. PubMed ID: 2825221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the kappa-opioid agonist U50,488 on parturition in rats.
    Douglas AJ; Clarke G; MacMillan SJ; Bull PM; Neumann I; Way SA; Wright DM; McGrory BG; Russell JA
    Br J Pharmacol; 1993 May; 109(1):251-8. PubMed ID: 8388299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat.
    Bolanos CA; Garmsen GM; Clair MA; McDougall SA
    Eur J Pharmacol; 1996 Dec; 317(1):1-8. PubMed ID: 8982712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of U50,488H on locomotor activity in the hamster.
    Schnur P; Walker JM
    Pharmacol Biochem Behav; 1990 Aug; 36(4):813-6. PubMed ID: 2170998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
    Gullapalli S; Ramarao P
    Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute and chronic administration of U50,488, a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa.
    Marin C; Bové J; Bonastre M; Tolosa E
    Exp Neurol; 2003 Sep; 183(1):66-73. PubMed ID: 12957489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of hypothermia in the guinea pig by a kappa-agonist opioid alone and in combination with chlorpromazine.
    Adler MW; Bradley E; Martinez R; Geller EB
    Pharmacol Biochem Behav; 1991 Sep; 40(1):129-32. PubMed ID: 1664107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.
    Bronson ME; Lin YP; Burchett K; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 1993; 111(1):69-77. PubMed ID: 7870936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
    Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H.
    Shieh GJ; Walters DE
    Neurosci Lett; 1994 Jul; 176(1):37-40. PubMed ID: 7970232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary modulation of mu and kappa opioid receptor-mediated analgesia.
    Kanarek RB; Przypek J; D'Anci KE; Marks-Kaufman R
    Pharmacol Biochem Behav; 1997 Sep; 58(1):43-9. PubMed ID: 9264068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.